Protecting Patients Against PBM Abuses Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Protecting Patients Against PBM Abuses Act (H.R. 2880) is a health policy bill introduced in the 118th Congress aimed at addressing issues related to pharmacy benefit managers (PBMs). While the official summary and full text are not available, the bill's title indicates a focus on regulating or reforming PBM practices to protect patients. The bill was referred to the House Subcommittee on Health but ultimately failed or expired without becoming law.
H.R. 2880 sought to regulate pharmacy benefit managers to protect patients but did not advance beyond subcommittee referral and expired without enactment.
- The bill targets abuses by pharmacy benefit managers (PBMs) in the healthcare system.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- The bill did not progress past the subcommittee stage and is classified as failed or expired.
['Patients who use prescription drug benefits managed by PBMs', 'Healthcare consumers concerned about PBM practices', 'Potentially healthcare providers and pharmacies affected by PBM regulations']
['Lack of available full text limits understanding of specific regulatory mechanisms or enforcement provisions', 'Unclear funding or authority changes related to PBM oversight', 'Potential implementation challenges in monitoring and enforcing new PBM rules', 'Tradeoffs between regulatory oversight and PBM operational flexibility']
The bill was introduced in the House of Representatives during the 118th Congress and referred to the Subcommittee on Health. It did not advance further and was classified as failed or expired by the update date in May 2025. The policy area is health, specifically focusing on pharmacy benefit managers, a topic of ongoing legislative interest related to drug pricing and healthcare costs.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could influence PBM business practices, potentially affecting drug pricing and pharmacy operations.', 'Changes in PBM regulation might impact insurance plan designs and patient out-of-pocket costs.', 'Increased oversight could lead to administrative costs for PBMs and related healthcare entities.']
The absence of the full bill text and official summary limits transparency and public understanding of the bill's specific provisions and potential impacts. Tracking the bill's referral to the Subcommittee on Health and its failure to advance highlights the importance of monitoring legislative progress and access to complete documentation for effective oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.